VIENNA 30 SEPTEMBER 3 OCTOBER
Europe's leading congress in skin and sexual health
Annual General Meeting
ELECTIONS CLOSING SOON
- ELECTIONS CLOSING SOON
Shape the future of the Academy and support the advancement in dermatology and venereology
EADV News Election special
FACE-TO-FACE COURSES
Latest Podcast episode
Melanoma diagnosis: why dermoscopy still leads the way
MyEADV Past Events Library
European Academy of Dermatology & Venereology
EADV is committed to building the international community that develops, shares, and adopts best practices within dermatology and venereology.
With over 14'000 members and an active community of more than 20'000 professionals around the world, our goal is to be the trusted source for proven scientific advancements and practices in the prevention, diagnosis, and treatment of skin and venereal diseases.
TOGETHER FOR BETTER
Latest news from the Academy


European Parliament recognised Women’s skin health burden
For the first time, Members of the European Parliament recognised the burden of skin diseases, particularly their disproportionate impact on women and girls, as well as their connection with cardiovascular diseases. EADV engaged with policymakers working on both reports, which now reflect key asks from the dermatology community.


Vol 5 Issue 3 of the JEACP is online
See the latest updates from JEADV Clinical Practice (JEACP), our open-access publication focused on clinical content and practical information.
In this issue: sensitive scalp, skin disease during pregnancy, skin frailty, juvenile mycosis fungoides, and more.


JEADV moves to Online-Only Publication
From January 2027, JEADV will move to online-only publication, supporting EADV’s sustainability goals while modernizing its publishing model and enhancing the experience for members and readers.


Vol 40 Issue 9 of the JEADV is online
See the latest updates on skin & venereal diseases from JEADV, our high-ranking international journal.
In this issue: psoriasis, litifilimab, IL-23 receptor inhibitor, squamous cell carcinoma, and more

